PharmaSGP Holding SE (PSG.DE)

EUR 23.8

(-4.03%)

Gross Profit Summary of PharmaSGP Holding SE

PharmaSGP Holding SE's latest annual gross profit in 2023 was 91.63 Million EUR , down -2.33% from previous year.
PharmaSGP Holding SE's latest quarterly gross profit in 2024 Q2 was 25.54 Million EUR , up 9.7% from previous quarter.
PharmaSGP Holding SE reported a annual gross profit of 76.79 Million EUR in annual gross profit 2022, up 30.47% from previous year.
PharmaSGP Holding SE reported a annual gross profit of 58.85 Million EUR in annual gross profit 2021, up 3.18% from previous year.
PharmaSGP Holding SE reported a quarterly gross profit of 25.54 Million EUR for 2024 Q2, up 9.7% from previous quarter.
PharmaSGP Holding SE reported a quarterly gross profit of 23.32 Million EUR for 2023 Q2, up 7.3% from previous quarter.

Annual Gross Profit Chart of PharmaSGP Holding SE (2023 - 2017)

Historical Annual Gross Profit of PharmaSGP Holding SE (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	91.63 Million EUR	-2.33%
2022	76.79 Million EUR	30.47%
2021	58.85 Million EUR	3.18%
2020	57.04 Million EUR	0.59%
2019	56.7 Million EUR	12.75%
2018	50.29 Million EUR	11.38%
2017	45.15 Million EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	23.28 Million EUR	25.31%
2024 Q2	25.54 Million EUR	9.7%
2023 Q2	23.32 Million EUR	7.3%
2023 Q1	21.73 Million EUR	10.22%
2023 FY	74.99 Million EUR	-2.33%
2023 Q4	18.58 Million EUR	-21.32%
2023 Q3	23.61 Million EUR	1.26%
2022 Q4	19.72 Million EUR	-0.31%
2022 Q3	19.78 Million EUR	3.39%
2022 Q2	19.13 Million EUR	5.39%
2022 Q1	18.15 Million EUR	8.99%
2022 FY	76.79 Million EUR	30.47%
2021 Q1	11.26 Million EUR	-10.96%
2021 Q4	16.65 Million EUR	-7.93%
2021 Q3	18.09 Million EUR	40.88%
2021 FY	58.85 Million EUR	3.18%
2021 Q2	12.84 Million EUR	14.0%
2020 Q2	15.52 Million EUR	0.0%
2020 FY	57.04 Million EUR	0.59%
2020 Q4	12.65 Million EUR	-5.13%
2020 Q3	13.33 Million EUR	-14.11%
2020 Q1	15.52 Million EUR	1.02%
2019 Q1	13.35 Million EUR	0.0%
2019 FY	56.7 Million EUR	12.75%
2019 Q4	15.36 Million EUR	19.86%
2019 Q3	12.82 Million EUR	-15.44%
2019 Q2	15.16 Million EUR	13.58%
2018 FY	50.29 Million EUR	11.38%
2017 FY	45.15 Million EUR	0.0%

Peer Gross Profit Comparison of PharmaSGP Holding SE

Name	Gross Profit	Gross Profit Difference
MPH Health Care AG	180.33 Million EUR	49.184%
Apontis Pharma AG	-3.33 Million EUR	2846.744%
Dermapharm Holding SE	342.86 Million EUR	73.273%
Evotec SE	175.05 Million EUR	47.651%
MERCK Kommanditgesellschaft auf Aktien	11.66 Billion EUR	99.215%
SynBiotic SE	1.5 Million EUR	-5983.106%